[go: up one dir, main page]

SI3908570T1 - Ketamin pamoat in njegova uporaba - Google Patents

Ketamin pamoat in njegova uporaba

Info

Publication number
SI3908570T1
SI3908570T1 SI202030367T SI202030367T SI3908570T1 SI 3908570 T1 SI3908570 T1 SI 3908570T1 SI 202030367 T SI202030367 T SI 202030367T SI 202030367 T SI202030367 T SI 202030367T SI 3908570 T1 SI3908570 T1 SI 3908570T1
Authority
SI
Slovenia
Prior art keywords
ketamine pamoate
pamoate
ketamine
Prior art date
Application number
SI202030367T
Other languages
English (en)
Inventor
Tong-Ho Lin
Yung-Shun Wen
Chia-Hsien Chen
Wei-Ju Chang
Original Assignee
Alar Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alar Pharmaceuticals Inc. filed Critical Alar Pharmaceuticals Inc.
Publication of SI3908570T1 publication Critical patent/SI3908570T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/105Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
    • C07C65/11Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI202030367T 2019-01-11 2020-01-10 Ketamin pamoat in njegova uporaba SI3908570T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962791058P 2019-01-11 2019-01-11
US201962871763P 2019-07-09 2019-07-09
EP20739053.5A EP3908570B1 (en) 2019-01-11 2020-01-10 Ketamine pamoate and use thereof
PCT/CN2020/071404 WO2020143762A1 (en) 2019-01-11 2020-01-10 Ketamine pamoate and use thereof

Publications (1)

Publication Number Publication Date
SI3908570T1 true SI3908570T1 (sl) 2024-04-30

Family

ID=71521952

Family Applications (1)

Application Number Title Priority Date Filing Date
SI202030367T SI3908570T1 (sl) 2019-01-11 2020-01-10 Ketamin pamoat in njegova uporaba

Country Status (28)

Country Link
US (1) US11981617B2 (sl)
EP (1) EP3908570B1 (sl)
JP (1) JP7451538B2 (sl)
KR (1) KR20210116517A (sl)
CN (1) CN113423686B (sl)
AU (1) AU2020206826B2 (sl)
BR (1) BR112021013340A2 (sl)
CA (1) CA3118954A1 (sl)
CL (1) CL2021001803A1 (sl)
CO (1) CO2021006884A2 (sl)
DK (1) DK3908570T3 (sl)
ES (1) ES2974259T3 (sl)
FI (1) FI3908570T3 (sl)
HR (1) HRP20240255T1 (sl)
HU (1) HUE065684T2 (sl)
LT (1) LT3908570T (sl)
MX (1) MX2021006029A (sl)
PE (1) PE20211550A1 (sl)
PH (1) PH12021551157A1 (sl)
PL (1) PL3908570T3 (sl)
PT (1) PT3908570T (sl)
RS (1) RS65271B1 (sl)
SG (1) SG11202104792SA (sl)
SI (1) SI3908570T1 (sl)
SM (1) SMT202400100T1 (sl)
TW (1) TWI827783B (sl)
WO (1) WO2020143762A1 (sl)
ZA (1) ZA202103132B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020016500A2 (pt) 2018-02-15 2020-12-15 National University Corporation Chiba University Agente preventivo ou terapêutico e composição farmacêutica para doença inflamatória ou doença óssea
WO2019213551A1 (en) 2018-05-04 2019-11-07 Perception Neuroscience, Inc. Methods of treating substance abuse
PE20231942A1 (es) * 2019-12-20 2023-12-05 Alar Pharmaceuticals Inc Formulaciones inyectables de accion prolongada de sales de pamoato de ketamina
US20210322669A1 (en) * 2020-04-16 2021-10-21 Invictus Health, Inc. Method for treatment of traumatic brain injuries
CN112263572A (zh) * 2020-11-17 2021-01-26 厦门大学附属翔安医院 右旋氯胺酮在制备治疗脱髓鞘疾病药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150524A0 (en) 2000-01-07 2003-02-12 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
US20080293695A1 (en) 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
US9421266B2 (en) 2007-05-22 2016-08-23 Pisgah Laboratories, Inc. Safety of pseudoephedrine drug products
JO2857B1 (en) 2008-06-16 2015-03-15 سانوفي أفينتس Vinyl pipers with modified activity of tumor-resistant TNF
JO3227B1 (ar) 2011-09-08 2018-03-08 Otsuka Pharma Co Ltd مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان
JP2014196292A (ja) 2013-03-07 2014-10-16 大塚製薬株式会社 医薬
CN106562952B (zh) * 2015-10-09 2020-06-09 江阴安博生物医药有限公司 氯胺酮在治疗重性抑郁障碍中的应用
AU2017242867B9 (en) 2016-03-29 2019-07-04 Shanghai Synergy Pharmaceutical Sciences Co., Ltd Vortioxetine pamoic acid salt and crystal form thereof
EP3558279A4 (en) 2016-12-26 2020-12-02 Cellix Bio Private Limited COMPOSITIONS AND PROCEDURES FOR TREATMENT OF CHRONIC PAIN
KR20230110828A (ko) * 2018-01-10 2023-07-25 엑스더블유파마 리미티드 케타민의 전구약물, 및 이의 조성물 및 용도

Also Published As

Publication number Publication date
EP3908570A4 (en) 2022-10-19
CL2021001803A1 (es) 2021-12-24
CO2021006884A2 (es) 2021-06-10
FI3908570T3 (fi) 2024-02-13
TWI827783B (zh) 2024-01-01
CN113423686A (zh) 2021-09-21
WO2020143762A1 (en) 2020-07-16
RS65271B1 (sr) 2024-03-29
AU2020206826B2 (en) 2024-05-02
CA3118954A1 (en) 2020-07-16
HUE065684T2 (hu) 2024-06-28
PH12021551157A1 (en) 2021-11-03
US20220119338A1 (en) 2022-04-21
SMT202400100T1 (it) 2024-05-14
EP3908570B1 (en) 2023-12-13
PE20211550A1 (es) 2021-08-16
JP7451538B2 (ja) 2024-03-18
DK3908570T3 (da) 2024-02-26
PL3908570T3 (pl) 2024-07-01
LT3908570T (lt) 2024-03-12
JP2022518003A (ja) 2022-03-11
CN113423686B (zh) 2023-08-22
AU2020206826A1 (en) 2021-06-03
ES2974259T3 (es) 2024-06-26
TW202042796A (zh) 2020-12-01
EP3908570A1 (en) 2021-11-17
KR20210116517A (ko) 2021-09-27
NZ775810A (en) 2024-07-26
HRP20240255T1 (hr) 2024-05-24
US11981617B2 (en) 2024-05-14
MX2021006029A (es) 2021-09-23
PT3908570T (pt) 2024-03-15
BR112021013340A2 (pt) 2021-09-14
SG11202104792SA (en) 2021-06-29
ZA202103132B (en) 2024-11-27

Similar Documents

Publication Publication Date Title
IL285178A (en) compounds and their use
SG11202104792SA (en) Ketamine pamoate and use thereof
IL292692A (en) mrgprx2 antagonists and their uses
IL286497A (en) compounds and their use
IL285177A (en) compounds and their use
IL287781A (en) Clec-12a binding polypeptides and uses thereof
IL282350A (en) Bernani-RGMC inhibitors and their use
SG11202009280RA (en) Compounds and uses thereof
IL287782A (en) 33cd-binding polypeptides and their uses
IL291499A (en) Azaquinoline compounds and their uses
IL285118A (en) compounds and their uses
IL292693A (en) mrgprx2 antagonists and their uses
IL284764A (en) compounds and their uses
IL280644A (en) Magnesium serine compound and its use
IL279483A (en) Cyanotriazole compounds and their uses
PL3774141T3 (pl) Hydrauliczny uchwyt rozprężny i jego zastosowanie
IL287503A (en) Thio-semicarbazide compounds and their use
IL289531A (en) cd38 binding agents and uses thereof
IL288828A (en) Binding factors - cd38 and their use
IL280369A (en) Myokines and their uses
GB201906914D0 (en) Substituted naphtahlene diimdes and their use
PT3617533T (pt) Parafuso e sua utilização
IL283540A (en) Dock1 inhibitory compound and use thereof
ZA202201239B (en) Aminothiolester compounds and uses thereof
IL278919A (en) Combinations comprising tropifexor and cenicriviroc